Search

Author/Creator Galloway, Christopher

1. Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment. (22nd November 2016)

Authors:
Katsube, Takayuki; Echols, Roger; Arjona Ferreira, Juan Camilo; Krenz, Heidi K.; Berg, Jolene Kay; Galloway, Christopher
Journal:
Journal of clinical pharmacology
Issue:
Volume 57:Number 5(2017)
Page Start:
584
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022)

Authors:
Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 12(2022)
Page Start:
1703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ‐56914845 (GSK2336805) in subjects with hepatic impairment. (25th May 2015)

Authors:
Adkison, Kimberly K.; Gan, Jianjun; Elko‐Simms, Lucinda; Gardner, Stephen; Dumont, Etienne; Jones, Lori S.; Saunders, Joanne; Marbury, Thomas; Smith, William; Berg, Jolene; Galloway, Christopher; Stump, Patrick J.
Journal:
Journal of clinical pharmacology
Issue:
Volume 55:Number 9(2015:Sep.)
Page Start:
1042
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗